US Stock MarketDetailed Quotes

BCYC Bicycle Therapeutics

Watchlist
  • 20.540
  • +0.280+1.38%
Close Nov 22 16:00 ET
  • 20.540
  • 0.0000.00%
Post 16:00 ET
1.42BMarket Cap-6262P/E (TTM)

About Bicycle Therapeutics Company

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Company Profile

SymbolBCYC
Company NameBicycle Therapeutics
Listing DateMay 23, 2019
Issue Price14.00
Founded2009
CEODr. Kevin Lee, M.B.A.
MarketNASDAQ
Employees284
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressGranta Park Great Abington,Portway Building,Blocks A & B
CityCambridge
ProvinceCambridgeshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeCB21 6GS
Phone44-1223-261503
Websitehttp://bicycletherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Kevin Lee, M.B.A.
  • Director and Chief Executive Officer
  • 5.54M
  • Dr. Michael Charles Ferguson Hannay, D.Sc.
  • Chief Product and Supply Chain Officer
  • --
  • Travis Thompson
  • Chief Accounting Officer
  • --
  • Nigel Crockett
  • Chief Business Officer
  • --
  • Alistair Milnes
  • Chief Operating Officer
  • --
  • Alethia Young
  • Chief Financial Officer
  • 2.88M
  • Dr. Nicholas Keen, PhD
  • Chief Scientific Officer
  • --
  • Dr. Santiago Arroyo
  • Chief Development Officer
  • 2.68M
  • Dr. Michael Skynner, PhD
  • Chief Technology Officer
  • --
  • Pierre Legault, C.P.A.,M.B.A.
  • Chairman of the Board
  • 1.06M
  • Dr. Felix J. Baker,PhD
  • Independent Director
  • --
  • Janice Bourque, M.B.A.
  • Independent Director
  • 495.41K
  • Dr. Jose-Carlos Gutierrez-Ramos, PhD
  • Independent Director
  • 482.29K
  • Stephen Sands
  • Independent Director
  • --
  • Sir Greg Winter, F.R.S.
  • Independent Director
  • 477.04K
  • Richard N. Kender, M.B.A.
  • Independent Director
  • 526.91K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data